ask="0.60"
ask_size="1300"
average_daily_volume="541121"
bid="0.58"
bid_size="1000"
book_value="1.64"
change="+0.01"
change_from_200_day_moving_average="-0.41"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-2.80"
change_From_52_week_low="0.05"
change_in_percent="+1.74%"
close="0.58"
dividend_pay_date="8/19/2015"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.59"
ebitda="-16.45M"
eps_estimate_current_year="-1.52"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.24"
ex_dividend_date="8/20/2015"
float_shares="5356000"
high="0.61"
high_52_weeks="3.38"
last_trade_date="1/31/2017"
last_trade_price="0.58"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.57"
low_52_weeks="0.53"
market_capitalization="6.98M"
moving_average_200_day="0.99"
moving_average_50_day="0.65"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.25"
open="0.57"
pe_ratio="N/A"
peg_ratio="0.02"
percent_change_from_200_day_moving_average="-41.12%"
percent_change_from_50_day_moving_average="-11.35%"
percent_change_from_52_week_high="-82.84%"
percent_change_from_52_week_low="+9.37%"
previous_close="0.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.35"
price_per_sales="15.69"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.09"
stock_exchange="NCM"
symbol="CBIO"
volume="88107"
weeks_range_52="0.53 - 3.38"
